Grape King BioTPE:1707 +0.66%79 Days Inventory is 107.06 as of Dec. 2025, which is 9% below its 10-year median of 117.10. GuruFocus rates TPE:1707 with a GF Score™ of 79/100 and a GF Value™ of NT$144.04 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 919 Drug Manufacturers companies, Grape King Bio ranks better than 73.23% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Grape King Bio's Average Total Inventories for the
three
months ended in Dec. 2025 was NT$829 Mil. Grape King Bio's Cost of Goods Sold for the
three
months ended in Dec. 2025 was NT$706 Mil.
Hence, Grape King Bio's Days Inventory for the
three
months ended in Dec. 2025 was 107.06.
The historical rank and industry rank for Grape King Bio's Days Inventory or its related term are showing as below:
TPE:1707'
s Days Inventory Range Over the Past 10 Years
Min: 103.84 Med: 117.1 Max: 138.25
Current: 114.17
During the past 13 years, Grape King Bio's highest Days Inventory was 138.25. The lowest was 103.84. And the median was 117.10.
TPE:1707's Days Inventory is ranked better than 73.23% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs TPE:1707: 114.17
Grape King Bio's Days Inventory
increased
from Dec. 2024 (104.35) to Dec. 2025 (107.06).
It might indicate that Grape King Bio's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Grape King Bio's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.85.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Grape King Bio's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.28.
Grape King Bio (TPE:1707) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Grape King Bio's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Grape King Bio's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Grape King Bio Days Inventory Related Terms
Grape King Bio Days Inventory Historical Data
* Premium members only.
The historical data trend for Grape King Bio's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grape King Bio Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Days Inventory distribution charts can be found below:
* The bar in red indicates where Grape King Bio's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grape King Bio (TPE:1707) has a Days Inventory of 107.06 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grape King Bio and its competitors. This is near median its historical median of 117.10. Over the past decade, Grape King Bio's Days Inventory has ranged from 103.84 to 138.25. According to the industry distribution chart, Grape King Bio ranks #246 out of 919 companies in the Drug Manufacturers industry, placing it in the top 26.8%.
Is Grape King Bio's Days Inventory too high?
Grape King Bio's current Days Inventory of 107.06 is near median its 10-year median of 117.10. Over the past 10 years, this metric has ranged from a low of 103.84 to a high of 138.25. The Drug Manufacturers industry median Days Inventory is 164.48. Grape King Bio's value of 107.06 is 34.9% below this industry median. Based on the distribution chart, Grape King Bio ranks #246 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Grape King Bio has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grape King Bio ranks #246 out of 919 companies for Days Inventory. This puts Grape King Bio in the upper half of its industry. The industry median Days Inventory is 164.48. Grape King Bio's value of 107.06 is 34.9% below this benchmark. Historically, Grape King Bio's own Days Inventory has ranged from 103.84 to 138.25 over the past decade. While the company's 10-year median is 117.10 vs. the industry median of 164.48, Grape King Bio has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grape King Bio's current Days Inventory of 107.06 is 34.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grape King Bio and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grape King Bio's current Days Inventory is 107.06, which is near median its own 10-year median of 117.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Possible Value Trap. The stock's GF Value™ is NT$144.04, compared to a current price of NT$91.60 — trading 36.4% below its estimated fair value. The current Days Inventory is 107.06, which is near median its 10-year median of 117.10 and 34.9% below the Drug Manufacturers industry median of 164.48. Grape King Bio's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Days Inventory is 107.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grape King Bio (TPE:1707) Overvalued in 2026?
Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued.
The current stock price of NT$91.60 is trading 36.4% below its estimated GF Value™ of NT$144.04.
GuruFocus considers Grape King Bio to be Possible Value Trap.
Key valuation signals for TPE:1707:
Days Inventory: 107.06 (near median its 10-year median of 117.10)
GF Value™: NT$144.04 vs. price of NT$91.60 (36.4% below fair value)
Industry Position: 34.9% below the Drug Manufacturers median (#246 of 919)
No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
79GF Score
Get the complete analysis for TPE:1707
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1707 has been successfully added to your 
